<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00543270</url>
  </required_header>
  <id_info>
    <org_study_id>TP00-005/CP04-001</org_study_id>
    <nct_id>NCT00543270</nct_id>
  </id_info>
  <brief_title>Powerlink Bifurcated Stent Graft Long-Term Follow-up Study</brief_title>
  <official_title>Endologix Powerlink Long-Term Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Endologix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endologix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endologix Infrarenal Bifurcated Stent Graft Study&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>No of Subjects with Major adverse events</measure>
    <time_frame>At 1 Year</time_frame>
    <description>Aneurysm-related mortality, aneurysm rupture, conversion to open repair, coronary intervention, myocardial infarction, renal failure, respiratory failure, secondary procedure, and stroke</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All Cause Mortality</measure>
    <time_frame>At 1 Year</time_frame>
    <description>No of deaths reported through 1 year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Performance</measure>
    <time_frame>30 Days</time_frame>
    <description>Total number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Performance</measure>
    <time_frame>6 Months</time_frame>
    <description>Total number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Performance</measure>
    <time_frame>Year 1</time_frame>
    <description>Total number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Performance</measure>
    <time_frame>Year 2</time_frame>
    <description>Total number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Performance</measure>
    <time_frame>Year 3</time_frame>
    <description>Total number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Performance</measure>
    <time_frame>Year 4</time_frame>
    <description>Total number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Graft Performance</measure>
    <time_frame>Year 5</time_frame>
    <description>Total number of Subjects with Stent fracture, Stent Graft Migration, Stent Graft patency and Device Migration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Utility Outcomes</measure>
    <time_frame>During the Procedure</time_frame>
    <description>Estimated anesthesia time, fluoroscopy time, procedure time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Utility Outcomes</measure>
    <time_frame>During the Procedure</time_frame>
    <description>Estimated blood loss (ml) and contrast volume (ml). Estimated blood loss records the approximate amount of blood that the patient lost during the surgery (ml) and contract volume is the volume of the contrast (ml) calculated during the procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Utility Outcomes</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Estimated ICU time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Utility Outcomes</measure>
    <time_frame>up to 1 week</time_frame>
    <description>Estimated Hospitalization Time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm Morphology</measure>
    <time_frame>6 Months</time_frame>
    <description>Change in aneurysm sac diameter from first post-procedural CT scan (30 days) to 6 Months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm Morphology</measure>
    <time_frame>Year 1</time_frame>
    <description>Change in aneurysm sac diameter from first post-procedural CT scan (30 days) to Year 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm Morphology</measure>
    <time_frame>Year 2</time_frame>
    <description>Change in aneurysm sac diameter from first post-procedural CT scan (30 days) to Year 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm Morphology</measure>
    <time_frame>Year 3</time_frame>
    <description>Change in aneurysm sac diameter from first post-procedural CT scan (30 days) to Year 3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm Morphology</measure>
    <time_frame>Year 4</time_frame>
    <description>Change in aneurysm sac diameter from first post-procedural CT scan (30 days) to Year 4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm Morphology</measure>
    <time_frame>Year 5</time_frame>
    <description>Change in aneurysm sac diameter from first post-procedural CT scan (30 days) to Year 5</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">258</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Endovascular Repair - EVAR (Powerlink System)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>EVAR (Powerlink System)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open Surgical Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Open Surgical Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Powerlink infrarenal bifurcated stent graft delivery system</intervention_name>
    <description>Endovascular abdominal aortic aneurysm repair</description>
    <arm_group_label>Endovascular Repair - EVAR (Powerlink System)</arm_group_label>
    <other_name>Powerlink Stent Graft Delivery System</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Surgery</intervention_name>
    <description>Open surgical abdominal aortic aneurysm repair</description>
    <arm_group_label>Open Surgical Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All surviving patients from the original study cohort who received the Powerlink&#xD;
             device&#xD;
&#xD;
          -  All surviving patients from the original study cohort who were assigned to the open&#xD;
             surgical control arm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodney White, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona Heart Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harbor-UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois School of Medicine</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SIU School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Vascular Associates</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Cardiovascular Research Group</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Hospital System</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Hospital of South Dakota</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular and Transplant Specialists</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Carpenter JP. The Powerlink bifurcated system for endovascular aortic aneurysm repair: four-year results of the US multicenter trial. J Cardiovasc Surg (Torino). 2006 Jun;47(3):239-43.</citation>
    <PMID>16760859</PMID>
  </results_reference>
  <results_reference>
    <citation>Parmer SS, Carpenter JP; Endologix Investigators. Endovascular aneurysm repair with suprarenal vs infrarenal fixation: a study of renal effects. J Vasc Surg. 2006 Jan;43(1):19-25.</citation>
    <PMID>16414382</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang GJ, Carpenter JP. EVAR in small versus large aneurysms: does size influence outcome? Vasc Endovascular Surg. 2009 Jun-Jul;43(3):244-51. doi: 10.1177/1538574408327570. Epub 2008 Dec 16.</citation>
    <PMID>19088132</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang GJ, Carpenter JP; Endologix Investigators. The Powerlink system for endovascular abdominal aortic aneurysm repair: six-year results. J Vasc Surg. 2008 Sep;48(3):535-45. doi: 10.1016/j.jvs.2008.04.031. Epub 2008 Jul 16.</citation>
    <PMID>18635335</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 10, 2007</study_first_submitted>
  <study_first_submitted_qc>October 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2007</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>EVAR</keyword>
  <keyword>AAA</keyword>
  <keyword>Aneurysm</keyword>
  <keyword>Powerlink</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

